Literature DB >> 25678367

Immunohistochemical Expression of p16 and p21 in Pituitary Tissue Adjacent to Pituitary Adenoma versus Pituitary Tissue Obtained at Autopsy: Is There a Difference?

Emilija Manojlovic Gacic1, Milica Skender-Gazibara, Ivan Soldatovic, Dusko Dundjerovic, Novica Boricic, Savo Raicevic, Vera Popovic.   

Abstract

Normal pituitary tissue is frequently used for comparison with protein expression in tumor tissue, being obtained either at surgery or at autopsy. p16 and p21 proteins are cyclin-dependent kinase inhibitors, belonging to INK4 and Cip/Kip family, respectively. Their expression is increased in response to DNA damage or other cellular stressors, resulting in the activation of cell cycle checkpoints. They also play important roles in cellular senescence. The purpose of this study was to investigate differences in p16 and p21 immunohistochemical expression in normal pituitary tissue adjacent to pituitary adenoma obtained during neurosurgical procedure with pituitary tissue obtained at autopsy, from patients who died from non-endocrinological diseases. Our results show significant difference in p16 nuclear and p21 cytoplasmic immunohistochemical expression between two types of normal pituitary tissues. One of the reasons for this difference could be the age of subjects because those who underwent autopsy for a non-endocrinological disease were significantly older than subjects who underwent neurosurgery for a pituitary adenoma. Our finding that differences are probably not influenced by postmortem changes is supported by no significant correlation between postmortem interval and immunohistochemical p16 and p21 expression. The influence of the presence of a pituitary adenoma could not be evaluated in these specimens.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25678367     DOI: 10.1007/s12022-015-9358-7

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  42 in total

Review 1.  p21Cip1/Waf1 protein and its function based on a subcellular localization [corrected].

Authors:  Jana Cmielová; M Rezáčová
Journal:  J Cell Biochem       Date:  2011-12       Impact factor: 4.429

2.  The opposite prognostic significance of nuclear and cytoplasmic p21 expression in resectable gastric cancer patients.

Authors:  Yefei Huang; Weimin Wang; Yansu Chen; Yulin Huang; Jianbing Zhang; Song He; Yongfei Tan; Fulin Qiang; Aiping Li; Oluf Dimitri Røe; Shouyu Wang; Yan Zhou; Jianwei Zhou
Journal:  J Gastroenterol       Date:  2013-10-15       Impact factor: 7.527

Review 3.  The role of chromatin reorganization in the process of cellular senescence.

Authors:  Kaoru Tominaga; Olivia M Pereira-Smith
Journal:  Curr Drug Targets       Date:  2012-12       Impact factor: 3.465

Review 4.  Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis.

Authors:  V S Romanov; V A Pospelov; T V Pospelova
Journal:  Biochemistry (Mosc)       Date:  2012-06       Impact factor: 2.487

5.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

6.  Oncogene-induced senescence in pituitary adenomas and carcinomas.

Authors:  Krystallenia I Alexandraki; Mohammed Munayem Khan; Harvinder S Chahal; Nadezhda S Dalantaeva; Giampaolo Trivellin; Dan M Berney; Philippe Caron; Vera Popovic; Marija Pfeifer; Suzanne Jordan; Márta Korbonits; Ashley B Grossman
Journal:  Hormones (Athens)       Date:  2012 Jul-Sep       Impact factor: 2.885

Review 7.  Mechanisms for pituitary tumorigenesis: the plastic pituitary.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 8.  Epigenetic change in pituitary tumorigenesis.

Authors:  W E Farrell; R N Clayton
Journal:  Endocr Relat Cancer       Date:  2003-06       Impact factor: 5.678

9.  The specificity and patterns of staining in human cells and tissues of p16INK4a antibodies demonstrate variant antigen binding.

Authors:  Magdalena Sawicka; Jeffrey Pawlikowski; Stephen Wilson; Dudley Ferdinando; Hong Wu; Peter David Adams; David Andrew Gunn; William Parish
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

10.  Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors.

Authors:  Leandro Machado Colli; Fabiano Saggioro; Luciano Neder Serafini; Renata Costa Camargo; Helio Rubens Machado; Ayrton Custodio Moreira; Sonir R Antonini; Margaret de Castro
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

View more
  3 in total

1.  Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma.

Authors:  Meng Wang; Chenxing Ji; Yichao Zhang; Zhiqiang Zhang; Yu Zhang; Huiping Guo; Nidan Qiao; Xiang Zhou; Xiaoyun Cao; Zhen Ye; Yifei Yu; Vladimir Melnikov; Wei Gong; Min He; Zhaoyun Zhang; Yao Zhao; Xuelong Wang; Gang Wei; Zhao Ye
Journal:  Endocrine       Date:  2022-08-10       Impact factor: 3.925

2.  Oncogene-Induced Senescence in Pituitary Adenomas--an Immunohistochemical Study.

Authors:  Emilija Manojlovic-Gacic; Milica Skender-Gazibara; Vera Popovic; Ivan Soldatovic; Novica Boricic; Savo Raicevic; Sandra Pekic; Mirjana Doknic; Dragana Miljic; Irina Alafuzoff; Fredrik Pontén; Olivera Casar-Borota
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

Review 3.  Architects of Pituitary Tumour Growth.

Authors:  Maria Eugenia Sabatino; Ezequiel Grondona; Ana Lucía De Paul
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.